tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CRMD Stock Latest News

DefenCath’s Strong Clinical and Economic Profile Underpins Buy Rating Despite Anticipated 2026 Pricing Headwinds
RatingsDefenCath’s Strong Clinical and Economic Profile Underpins Buy Rating Despite Anticipated 2026 Pricing Headwinds
7d ago
CRMD
CorMedix announces interim results for DefenCath
PremiumThe Fly
CorMedix announces interim results for DefenCath
7d ago
CRMD
Cormedix’s Promising Outlook: Strong Financial Performance, Strategic Acquisition, and Growth Catalysts Justify Buy Rating
PremiumRatings
Cormedix’s Promising Outlook: Strong Financial Performance, Strategic Acquisition, and Growth Catalysts Justify Buy Rating
1M ago
CRMD
CorMedix price target raised to $18 from $17 at H.C. Wainwright
PremiumThe Fly
CorMedix price target raised to $18 from $17 at H.C. Wainwright
1M ago
CRMD
CorMedix Inc. Reports Strong Q3 2025 Financial Results
PremiumCompany Announcements
CorMedix Inc. Reports Strong Q3 2025 Financial Results
1M ago
CRMD
CorMedix Inc. Reports Record Earnings and Strategic Growth
PremiumCompany AnnouncementsCorMedix Inc. Reports Record Earnings and Strategic Growth
1M ago
CRMD
Cormedix: Buy Rating Affirmed Amid Strong Sales and Future Growth Catalysts
Premium
Ratings
Cormedix: Buy Rating Affirmed Amid Strong Sales and Future Growth Catalysts
1M ago
CRMD
CorMedix reports Q3 EPS $1.26, consensus 63c
Premium
The Fly
CorMedix reports Q3 EPS $1.26, consensus 63c
1M ago
CRMD
CorMedix sees FY25 pro forma revenue $390M-$410M
PremiumThe Fly
CorMedix sees FY25 pro forma revenue $390M-$410M
1M ago
CRMD
Is CRMD a Buy, Before Earnings?
PremiumPre-Earnings
Is CRMD a Buy, Before Earnings?
2M ago
CRMD
CorMedix Inc. Advances DEFENCATH® Trial to Combat CLABSIs
PremiumCompany Announcements
CorMedix Inc. Advances DEFENCATH® Trial to Combat CLABSIs
2M ago
CRMD
CorMedix Inc. Advances Pediatric Study on DefenCath® for Infection Prevention
PremiumCompany Announcements
CorMedix Inc. Advances Pediatric Study on DefenCath® for Infection Prevention
2M ago
CRMD
CorMedix receives Innovative Technology designation from Vizient
PremiumThe FlyCorMedix receives Innovative Technology designation from Vizient
2M ago
CRMD
CorMedix price target raised to $22 from $21 at RBC Capital
Premium
The Fly
CorMedix price target raised to $22 from $21 at RBC Capital
2M ago
CRMD
Cormedix’s Strong Financial Performance and Promising Prospects Drive Buy Rating
Premium
Ratings
Cormedix’s Strong Financial Performance and Promising Prospects Drive Buy Rating
2M ago
CRMD
Midday Fly By: AWS hit by outage, Kering sells beauty unit
PremiumThe Fly
Midday Fly By: AWS hit by outage, Kering sells beauty unit
2M ago
BA
DX
Morning Movers: Cleveland-Cliffs surges following earnings report
PremiumThe Fly
Morning Movers: Cleveland-Cliffs surges following earnings report
2M ago
CLF
COO
CorMedix upgraded to Buy from Hold at D. Boral Capital
PremiumThe Fly
CorMedix upgraded to Buy from Hold at D. Boral Capital
2M ago
CRMD
CorMedix reports preliminary Q3 unaudited net revenue more than $100M
PremiumThe Fly
CorMedix reports preliminary Q3 unaudited net revenue more than $100M
2M ago
CRMD
CorMedix raises FY25 pro forma net revenue view to $375M from $325M-$350M
PremiumThe FlyCorMedix raises FY25 pro forma net revenue view to $375M from $325M-$350M
2M ago
CRMD
CorMedix files to sell 6.32M shares of common stock for holders
Premium
The Fly
CorMedix files to sell 6.32M shares of common stock for holders
3M ago
CRMD
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
3M ago
SLI
VOR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >